IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel
FY2000 Appropriations: NIH Gets $17.9 Billion, A 15% Increase, In Final Budget Agreement; $3 billion to Be Delayed
Letter to the Editor: A Victory for Research, But Real Work Is Ahead
Commentary: NCI’s Budge Proposal ForFY2001 Offers A Blueprint for Research
Science Policy: Second-Hand Smoke Linked To Lung Cancer, Other Health Effects
Funding Opportunities: RFA Available: Teams For Molecular Target Assessment
In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End
Trending Stories
- She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology - HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Imaging’s ride to the bottom in clinical trials—and why it matters now
- In The Headlines: What happens when you apply a tumor board model to financial toxicity?
